
    
      The primary objective of this study is to evaluate the efficacy of a single 400 mg dose of
      intravenous ibuprofen on reducing fever greater than or equal to 101.0ºF (38.3ºC), as
      compared with the efficacy of parallel placebo treatment.
    
  